MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Predictors of quality of life in Machado-Joseph disease: A longitudinal observational study

I. Cunha, P. Silva, J. A Ribeiro, M. Santana, L. P Almeida, C. Januário (Coimbra, Portugal)

Meeting: MDS Virtual Congress 2020

Abstract Number: 1229

Keywords: Ataxia: Genetics, Depression, Familial neurodegenerative diseases

Category: Quality Of Life/Caregiver Burden in Movement Disorders

Objective: Determine the influence of clinical symptoms on QoL in patients with Machado-Joseph disease (MJD).

Background: MJD is a rare inherited neurodegenerative disorder. Its phenotypical expression is polymorphic, with pyramidal, extrapyramidal, cerebellar, brainstem, peripheral nerve and cognitive involvement. Quality of Life (QoL) is influenced by all these domains.

Method: A longitudinal observational study was performed in 25 MJD patients in a tertiary centre. Each patient was characterized in the following domains: ataxia(SARA score), non-ataxia signs(INAS score), cognitive function(MoCA score), sleep(PSQI), depression(PHQ9), functional severity (CCFS) and QoL (ADL and EQ-5D-3L). We compared two groups over one year: 15 patients stated that their disease status remained equal(group 1) and other 10 that their disease status has worsened(group 2). Descriptive and comparative statistical analysis was performed, defining p<0.05 as statistically significant.

Results: Patients stating worsening in disease status are more depressed that patients which their disease status remained stable (p=0.0293). Using only the EQ-visual analogue scale, these patients also express that their global health status is worse comparing to those who do not perceive a change in the disease status (p=0.0322). There is a positive correlation between SARA and EQ-5D-3L (ρ=0.461,p=0.0367) and a tendency for patients with worst QoL to have more non-ataxic symptomatology (p=0.0661). Despite patient’s global opinion on worsening disease status, no differences were observed between the two groups for other clinical scales.

Conclusion: In our group, non-ataxic symptoms (especially depression) seem to negatively influence QoL. These should be thoroughly addressed in these patients with validated depression scales, and are amenable to therapeutic intervention.

To cite this abstract in AMA style:

I. Cunha, P. Silva, J. A Ribeiro, M. Santana, L. P Almeida, C. Januário. Predictors of quality of life in Machado-Joseph disease: A longitudinal observational study [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/predictors-of-quality-of-life-in-machado-joseph-disease-a-longitudinal-observational-study/. Accessed May 13, 2025.
  • Tweet
  • Email
  • Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/predictors-of-quality-of-life-in-machado-joseph-disease-a-longitudinal-observational-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley